학술논문
A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years and older
Document Type
Article
Author
Source
In Vaccine 19 April 2024 42(11):2858-2866
Subject
Language
ISSN
0264-410X